Artesunate Injection is a potent antimalarial injectable formulation specifically used in the treatment of malaria, including severe and cerebral malaria. It is an essential medication recommended by healthcare professionals for rapid parasite clearance in infected individuals. The injection facilitates quick therapeutic action, making it indispensable in treating complicated malaria cases where oral administration may be ineffective. Artesunate Injection ensures effective management of malaria symptoms and complications, reducing mortality and morbidity associated with the disease. It is suitable for hospital and clinical use where intravenous or intramuscular administration is necessary for prompt clinical improvement.
Key Features
| Features | Description |
|---|---|
| Active Ingredient | Artesunate |
| Therapeutic Use | Treatment of malaria and cerebral malaria |
| Administration Route | Intravenous or Intramuscular injection |
| Formulation | Sterile injectable solution |
| Speed of Action | Rapid parasite clearance in severe malaria |
| Indication | Effective in complicated, severe, and cerebral malaria cases |
| Target Users | Hospitals, clinics, healthcare professionals |
| Storage Conditions | Store below 30°C, protect from light |
| Dosage Form | Injection vial |
| Attributes | Description |
|---|---|
| Dosage Strength | Typically 60 mg or 120 mg per vial |
| Packing | Single-use vial |
| Stability | Stable at room temperature when stored as recommended |
| Shelf Life | Generally 24 months from manufacturing |
| Regulatory Approvals | Must meet WHO prequalification or equivalent |
| Pharmacological Class | Antimalarial (Artemisinin derivative) |
| Contraindications | Known hypersensitivity to Artesunate or related compounds |
*Disclaimer: The above description has been AI-generated and has not been audited or verified for accuracy. It is recommended to verify product details independently before making any purchasing decisions.
Artesunate Injection is administered intravenously or intramuscularly depending on clinical condition and medical guidelines to ensure rapid and effective treatment in cerebral malaria.
The injection should be stored below 30°C, protected from light, and used before the expiry date to maintain efficacy.
Artesunate Injection is primarily used for severe and cerebral malaria cases. Uncomplicated malaria treatment may require oral antimalarials unless intravenous treatment is medically indicated.
Providers should ensure proper dosing, monitor for hypersensitivity reactions, and use only sterile equipment to prevent infections.
Yes, patients with known hypersensitivity to artesunate or related compounds should avoid this injection.
Arterolane is used in the treatment of malaria and Cerebral malaria.
